GLUD1 and Parkinson disease: Available mutations of GDH with uncertain pathogenicity and a potential effect of both GLUD1 and GLUD2 on the development of age-related neurological disorders, including Alzheimer’s and Parkinson’s disease [71,112], provide valuable material for further evaluation of the clinical role of both GDH genes in patients.